Not Tagged
Not Tagged
['prostate', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
fully agree. from my point of view there is no support for using a parpi in 1l mcrpc in all comers w/o os survival and significant toxicities. we need well designed trials to demonstrate os in the hrr-mutated setting, where the benefit seems more clear. #gu23 #prostatecancer 
Jefe de Servicio de Oncología Médica. Hospital Universitario Lucus Augusti, HULA. Grupo de Investigación Oncológica Traslacional, GIOT HULA. Cuenta personal